Certara Corp - CERT Quarterly EPS earnings growth
Certara, Inc. (CERT) develops FDA-approved benchmark biosimulation IT tools, making software migration critical for its clients. The quarterly EPS growth index confirms the effectiveness of AI implementation and the reduction of trial costs, while the value of -318.10 expresses the metric level. Business stability relies on a monopoly status in modeling, despite the dependence on the R&D budgets of major pharmaceutical companies.
%20Quarterly%20EPS%20earnings%20growth&width=1200&height=400&colorIndex=0&v=mwejrfjc.e5f-7d7lczk&start=20220704&end=20261113&filename=GURU_Markets_-_CERT_-_Certara-Inc._-_Quarterly-EPS-earnings-growth "CERT certara.com Year-over-year earnings per share growth for the last twelve months (07/04/2022 - 11/13/2026) | 👁️GURU.Markets👁️")
Certara Software (CERT) - metric breakdowns and financial figures
- share price and consensus valuation forecast:
- issuer market value details:
- balance sheet net asset value indicators:
- debt and liquidity data:
Total Debt to Equity Ratio Certara, Inc.|CERT - Long-Term Debt to Capital Coefficient|Short-Term Debt to Capital Certara, Inc.|CERT - Company Total Debt Obligations|Debt to Book Capitalization Ratio Certara Corp|CERT - Company Long-Term Indebtedness|Company Short-Term Debts Certara|Quick Liquidity Indicator certara.com
- earnings and market multiples details:
CERT - Net Financial Result|Projected Future Earnings Certara, Inc.|CERT - Price to Earnings Ratio|Forward P/E Multiple Certara Corp|CERT - Price to Earnings Adjusted for Growth Rate|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Certara Corp|CERT - Income before deduction of interest, taxes and amortization|Net earnings per share for the last 12 months Certara|CERT - Earnings per share for the last four quarters|Quarterly EPS earnings growth certara.com|CERT - Expected net earnings per share growth this year|Expected earnings per share growth for next year Certara, Inc.
Analysis of all company metrics:Certara, Inc.
Certara, Inc. (CERT) leverages its status as an indispensable biosimulation provider for the FDA to convert intellectual superiority into a stable cash flow. The quarterly EPS growth rate measures the dynamics of net profit per share, reflecting the actual efficiency of capital management. An upward trend in this curve confirms the scaling of a B2B monopoly, while a decline signals market saturation. Investors utilize this indicator to separate speculative noise from fundamental growth.
Key competitors
VEEV (Veeva) - Year-over-year net earnings per share growth for the last 12 months|DOCS: Year-over-year earnings per share growth rate for the last twelve months|HQY (HealthEquity Corp) - Quarterly EPS earnings growth|Quarterly EPS earnings growth Waystar Corp|Year-over-year earnings per share growth for the last twelve months CorVel Corporation (CRVL)|PRVA (priviahealth.com) - Year-over-year earnings per one share growth for the last 12 months|Quarterly EPS earnings growth HURN (Huron)|Quarterly EPS earnings growth Omnicell Inc OMCL|GDRX: Year-over-year net earnings per share growth for the last 12 months|Year-over-year earnings per one share growth for the last 12 months SDGR (Schrodinger Corp)|PHR: Quarterly EPS earnings growth|OMDA - Year-over-year net earnings per share change for the last twelve months|Year-over-year earnings per share growth for the last twelve months Evolent Health|Year-over-year earnings per share growth for the last 12 months HSTM (HealthStream Inc)|Quarterly EPS earnings growth DH|Year-over-year net earnings per share growth for the last 12 months Consensus Corp CCSI|Agilon Health - Year-over-year net earnings per share growth for the last 12 months|Year-over-year net earnings per share change for the last twelve months absci.com (ABSI)|So-Young International Inc. - Quarterly EPS earnings growth|National Research Corporation (NRC) - Year-over-year net earnings per share growth for the last 12 months|SPOK: Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months OptimizeRx Inc. (OPRX)|Year-over-year earnings per share growth for the last twelve months TruBridge, Inc.|SLP: Year-over-year earnings per one share growth for the last 12 months|Year-over-year net earnings per share growth for the last 12 months SOPH (SOPHiA GENETICS SA)|Year-over-year earnings per share growth rate for the last twelve months HCAT|Quarterly EPS earnings growth CCLD (CareCloud)|Year-over-year net earnings per share change for the last twelve months researchsolutions.com (RSSS)|DLHC: Year-over-year net earnings per share growth for the last 12 months|OneMedNet Corporation - Year-over-year earnings per share growth rate for the last twelve months|SCNX (Scienture) - Year-over-year net earnings per share growth for the last 12 months|Healthcare Triangle Inc - Year-over-year earnings per one share growth for the last 12 months|Year-over-year earnings per share growth for the last twelve months iSpecimen Inc|Year-over-year net earnings per share growth for the last 12 months Bullfrog AI Holdings Inc (BFRG)|Quarterly EPS earnings growth WORX|MSPR - Earnings per share growth in annualized terms for the last twelve months|Quarterly EPS earnings growth ICCT (iCoreConnect)|MEDS: Year-over-year earnings per share growth for the last 12 months|Orgenesis Corp - Quarterly EPS earnings growth|R1 RCM Inc. (RCM) - Year-over-year net earnings per share growth for the last 12 months|SHCR: Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months streamlinehealth.net (STRM)|Year-over-year earnings per share growth for the last twelve months Syra Health|AMEH: Year-over-year earnings per one share growth for the last 12 months|Year-over-year net earnings per share growth for the last 12 months MODN (Model N Corp)|Year-over-year earnings per share growth rate for the last twelve months NXGN
